首页 > 最新文献

Biomaterials, artificial cells, and immobilization biotechnology : official journal of the International Society for Artificial Cells and Immobilization Biotechnology最新文献

英文 中文
Polydisperse dextran as a diffusing test solute to study the membrane permeability of alginate polylysine microcapsules. 以多分散葡聚糖为扩散试验溶质,研究海藻酸盐聚赖氨酸微胶囊的膜透性。
V Coromili, T M Chang

Applications of alginate polylysine (APL) microcapsules in cell culture engineering and hybrid artificial organs require strict control of membrane permeability. For example, hybrid artificial organs must permit the diffusion of smaller molecules including peptides and proteins and the exclusion of leucocytes and immunoglobulins (MW > 150,000). Single molecular weight solutes such as proteins have been used to study the molecular weight cut-off of the membrane. A new approach that uses a heterogenous mixture of dextrans of different molecular weights: -MW 10,000-500,000 as a test solute in diffusion experiments is described. Intra/extra capsular changes in concentration and molecular weight distribution of the heterogenous dextran mixture are monitored and determined by high performance gel chromatography. MW can then be related to diffusional Stokes radius, a more useful parameter when comparing permeability of cell membrane to different test solutes.

海藻酸聚赖氨酸(APL)微胶囊在细胞培养工程和杂交人工器官中的应用要求严格控制膜的通透性。例如,混合人工器官必须允许包括多肽和蛋白质在内的小分子扩散,并排除白细胞和免疫球蛋白(MW > 150,000)。单分子量溶质(如蛋白质)已被用于研究膜的分子量切断。描述了一种新的方法,使用不同分子量的葡聚糖的异相混合物:-MW 10,000-500,000作为扩散实验中的测试溶质。采用高效凝胶色谱法监测和测定了多相葡聚糖混合物胶囊内/外浓度和分子量分布的变化。然后,MW可以与扩散斯托克斯半径相关联,这是比较细胞膜对不同测试溶质的渗透性时更有用的参数。
{"title":"Polydisperse dextran as a diffusing test solute to study the membrane permeability of alginate polylysine microcapsules.","authors":"V Coromili,&nbsp;T M Chang","doi":"10.3109/10731199309117382","DOIUrl":"https://doi.org/10.3109/10731199309117382","url":null,"abstract":"<p><p>Applications of alginate polylysine (APL) microcapsules in cell culture engineering and hybrid artificial organs require strict control of membrane permeability. For example, hybrid artificial organs must permit the diffusion of smaller molecules including peptides and proteins and the exclusion of leucocytes and immunoglobulins (MW > 150,000). Single molecular weight solutes such as proteins have been used to study the molecular weight cut-off of the membrane. A new approach that uses a heterogenous mixture of dextrans of different molecular weights: -MW 10,000-500,000 as a test solute in diffusion experiments is described. Intra/extra capsular changes in concentration and molecular weight distribution of the heterogenous dextran mixture are monitored and determined by high performance gel chromatography. MW can then be related to diffusional Stokes radius, a more useful parameter when comparing permeability of cell membrane to different test solutes.</p>","PeriodicalId":77039,"journal":{"name":"Biomaterials, artificial cells, and immobilization biotechnology : official journal of the International Society for Artificial Cells and Immobilization Biotechnology","volume":"21 3","pages":"427-44"},"PeriodicalIF":0.0,"publicationDate":"1993-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3109/10731199309117382","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18695384","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 41
Evaluation of 90:10 poly(D,L-lactide-co-glycolide) microspheres containing norethisterone: drug release and biodegradation. 90:10聚(D, l -丙交酯-羟基乙酸酯)含去甲睾酮微球的评价:药物释放和生物降解。
Z Zhou, M Zhou, Z Shen, W Shen

Poly(D,L-lactide-co-glycolide) (PLG, 90:10) microspheres containing 20% norethisterone (NET) were prepared by solvent evaporation method. Microspheres in the size ranges of 65 to 100 microns were sterilized by irradiation and used for further study. In vitro release showed fairly constant release of NET from the above microspheres over more than 90 days. However, in vivo drug release determined by residual NET analysis after i.m. injection in rats indicated a faster release rate. About 95% of NET was released in a period of 45 days. At the dose of 80 mg of microspheres, vaginal estrus cycles were inhibited for 45 days compared to 27 days for the same dose of NET crystals in rats. Biodegradation of the microspheres was tested by direct measurement of molecular weight losses and SEM observation of morphological changes of the microspheres, which showed continuous erosion in the internal matrix of microspheres with the decrease of molecular weight of PLG until total collapse of microspheres, and biodegradation was faster in rats than in human serum at 37 degrees C in vitro. Total degradation of 90:10 PLG microspheres was less than 7 months in rats and more than 9 months in vitro.

采用溶剂蒸发法制备了含20%去甾酮(NET)的聚(D, l -丙交酯-羟基乙酸酯)(PLG, 90:10)微球。65 ~ 100微米的微球经辐照灭菌后用于进一步研究。体外释放表明,在超过90天的时间内,上述微球的NET释放相当稳定。然而,大鼠体内注射后残留NET分析的药物释放量显示出更快的释放速度。大约95%的。NET是在45天内发布的。在80 mg微球剂量下,大鼠阴道发情周期被抑制45天,而相同剂量的NET晶体则被抑制27天。通过直接测量分子量损失和扫描电镜观察微球的形态变化来检测微球的生物降解情况,微球的内部基质随着PLG分子量的降低而不断被侵蚀,直至微球完全崩溃,并且在体外37℃条件下,大鼠的生物降解速度快于人血清。90:10 PLG微球在大鼠体内总降解时间小于7个月,在体外降解时间大于9个月。
{"title":"Evaluation of 90:10 poly(D,L-lactide-co-glycolide) microspheres containing norethisterone: drug release and biodegradation.","authors":"Z Zhou,&nbsp;M Zhou,&nbsp;Z Shen,&nbsp;W Shen","doi":"10.3109/10731199309117653","DOIUrl":"https://doi.org/10.3109/10731199309117653","url":null,"abstract":"<p><p>Poly(D,L-lactide-co-glycolide) (PLG, 90:10) microspheres containing 20% norethisterone (NET) were prepared by solvent evaporation method. Microspheres in the size ranges of 65 to 100 microns were sterilized by irradiation and used for further study. In vitro release showed fairly constant release of NET from the above microspheres over more than 90 days. However, in vivo drug release determined by residual NET analysis after i.m. injection in rats indicated a faster release rate. About 95% of NET was released in a period of 45 days. At the dose of 80 mg of microspheres, vaginal estrus cycles were inhibited for 45 days compared to 27 days for the same dose of NET crystals in rats. Biodegradation of the microspheres was tested by direct measurement of molecular weight losses and SEM observation of morphological changes of the microspheres, which showed continuous erosion in the internal matrix of microspheres with the decrease of molecular weight of PLG until total collapse of microspheres, and biodegradation was faster in rats than in human serum at 37 degrees C in vitro. Total degradation of 90:10 PLG microspheres was less than 7 months in rats and more than 9 months in vitro.</p>","PeriodicalId":77039,"journal":{"name":"Biomaterials, artificial cells, and immobilization biotechnology : official journal of the International Society for Artificial Cells and Immobilization Biotechnology","volume":"21 4","pages":"475-86"},"PeriodicalIF":0.0,"publicationDate":"1993-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3109/10731199309117653","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19249880","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Hemoperfusion and liver disease. 血液灌流和肝脏疾病
G Visco, R Giannuzzi, M G Paglia, U Visco Comandini

After first adventurous attempts to apply perfusion techniques to the treatment of liver diseases, more extensive experiences have been acquired in the last twenty years, not only in acute hepatic failure but also in some chronic liver diseases (mainly in CAH:chronic active hepatitis, and in primary biliary cirrhosis) and in a severe complication of them, that is cryoglobulinemia. Some experiences on this field that are found in literature, using both plasma exchange and hemoperfusion, are reviewed and some personal data are reported: 15 patients with acute viral liver failure (survival rate: 33%) and 5 patients with a CAH-linked (3 viral and 2 autoimmune) cryoglobulinemia, in whom a good control of the disease parameters was obtained.

在首次大胆尝试将灌注技术应用于肝病治疗之后,在过去的二十年中获得了更广泛的经验,不仅在急性肝功能衰竭方面,而且在一些慢性肝病(主要是CAH:慢性活动性肝炎和原发性胆汁性肝硬化)以及它们的严重并发症,即冷球蛋白血症方面。本文回顾了文献中在该领域的一些经验,采用血浆置换和血液灌流两种方法,并报告了一些个人资料:15例急性病毒性肝衰竭(生存率33%)和5例cah -联(3例病毒和2例自身免疫性)冷球蛋白血症,这些患者的疾病参数得到了很好的控制。
{"title":"Hemoperfusion and liver disease.","authors":"G Visco,&nbsp;R Giannuzzi,&nbsp;M G Paglia,&nbsp;U Visco Comandini","doi":"10.3109/10731199309117363","DOIUrl":"https://doi.org/10.3109/10731199309117363","url":null,"abstract":"<p><p>After first adventurous attempts to apply perfusion techniques to the treatment of liver diseases, more extensive experiences have been acquired in the last twenty years, not only in acute hepatic failure but also in some chronic liver diseases (mainly in CAH:chronic active hepatitis, and in primary biliary cirrhosis) and in a severe complication of them, that is cryoglobulinemia. Some experiences on this field that are found in literature, using both plasma exchange and hemoperfusion, are reviewed and some personal data are reported: 15 patients with acute viral liver failure (survival rate: 33%) and 5 patients with a CAH-linked (3 viral and 2 autoimmune) cryoglobulinemia, in whom a good control of the disease parameters was obtained.</p>","PeriodicalId":77039,"journal":{"name":"Biomaterials, artificial cells, and immobilization biotechnology : official journal of the International Society for Artificial Cells and Immobilization Biotechnology","volume":"21 2","pages":"265-81"},"PeriodicalIF":0.0,"publicationDate":"1993-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3109/10731199309117363","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19305925","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Biocompatibility of alkyl and perfluoroalkyl telomeric surfactants derived from THAM. 烷基和全氟烷基端粒表面活性剂的生物相容性。
L Zarif, J G Riess, B Pucci, A A Pavia

A preliminary, comparative biological evaluation of two new families of non-ionic telomeric surfactants derived from Tris(hydroxymethyl)acrylaminomethane (THAM) is reported. These trisacryl conjugates, or TAC, were designed with the purpose of improving the stability and biocompatibility of fluorocarbon emulsions to be used in injectable oxygen-delivering systems. Their amphiphilic character arises from the simultaneous presence in the same molecule of several hydrophilic THAM residues and of a hydrophobic tail consisting in either a hydrocarbon (H-TAC family) or a fluorocarbon (F-TAC family) chain. The acute toxicity in mice after intravenous injection is low (LD50 in the 625 to 1250 mg/kg body weight range for the H-TAC compared to 630 to 4500 mg/kg body weight range for F-TAC) and increases with the length of the hydrophobic chain. No hemolytic activity was detected for the F-TAC at concentrations up to 200 g/l, while hemolysis is found for the H-TAC at a concentration of 5 g/l or less and increases with the alkyl chain length. The impact of the new surfactants on the growth and viability of Namalva cell cultures also increases with the length of the hydrophobic chain, with again a better tolerance for the F-TAC. Altogether the fluorinated amphiphiles display better tolerance than their hydrocarbon analogs in spite of their significantly increased surface activity. Both families of compounds appear to have potential as strongly hydrophilic surfactants for biomedical applications.

报道了两个新的非离子型端粒表面活性剂家族的初步比较生物学评价,这些表面活性剂是从Tris(羟甲基)丙烯酰胺甲烷(THAM)中提取的。这些三丙烯酸酯缀合物(TAC)的设计目的是提高用于可注射氧输送系统的氟碳乳液的稳定性和生物相容性。它们的两亲性是由于在同一分子中同时存在几个亲水的THAM残基和一个由碳氢化合物(H-TAC家族)或碳氟化合物(F-TAC家族)链组成的疏水尾部。静脉注射后小鼠的急性毒性较低(H-TAC的LD50在625至1250 mg/kg体重范围内,而F-TAC的LD50在630至4500 mg/kg体重范围内),并且随着疏水链的长度而增加。当浓度达到200 g/l时,F-TAC没有检测到溶血活性,而H-TAC在浓度为5 g/l或更低时则有溶血活性,并且随着烷基链长度的增加而增加。新的表面活性剂对Namalva细胞培养物的生长和活力的影响也随着疏水链的长度而增加,对F-TAC的耐受性也更好。总的来说,氟化两亲体表现出比它们的碳氢化合物类似物更好的耐受性,尽管它们的表面活性显著增加。这两个化合物家族似乎都有潜力作为生物医学应用的强亲水性表面活性剂。
{"title":"Biocompatibility of alkyl and perfluoroalkyl telomeric surfactants derived from THAM.","authors":"L Zarif,&nbsp;J G Riess,&nbsp;B Pucci,&nbsp;A A Pavia","doi":"10.3109/10731199309117384","DOIUrl":"https://doi.org/10.3109/10731199309117384","url":null,"abstract":"<p><p>A preliminary, comparative biological evaluation of two new families of non-ionic telomeric surfactants derived from Tris(hydroxymethyl)acrylaminomethane (THAM) is reported. These trisacryl conjugates, or TAC, were designed with the purpose of improving the stability and biocompatibility of fluorocarbon emulsions to be used in injectable oxygen-delivering systems. Their amphiphilic character arises from the simultaneous presence in the same molecule of several hydrophilic THAM residues and of a hydrophobic tail consisting in either a hydrocarbon (H-TAC family) or a fluorocarbon (F-TAC family) chain. The acute toxicity in mice after intravenous injection is low (LD50 in the 625 to 1250 mg/kg body weight range for the H-TAC compared to 630 to 4500 mg/kg body weight range for F-TAC) and increases with the length of the hydrophobic chain. No hemolytic activity was detected for the F-TAC at concentrations up to 200 g/l, while hemolysis is found for the H-TAC at a concentration of 5 g/l or less and increases with the alkyl chain length. The impact of the new surfactants on the growth and viability of Namalva cell cultures also increases with the length of the hydrophobic chain, with again a better tolerance for the F-TAC. Altogether the fluorinated amphiphiles display better tolerance than their hydrocarbon analogs in spite of their significantly increased surface activity. Both families of compounds appear to have potential as strongly hydrophilic surfactants for biomedical applications.</p>","PeriodicalId":77039,"journal":{"name":"Biomaterials, artificial cells, and immobilization biotechnology : official journal of the International Society for Artificial Cells and Immobilization Biotechnology","volume":"21 5","pages":"597-608"},"PeriodicalIF":0.0,"publicationDate":"1993-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3109/10731199309117384","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19109746","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 15
The long-term observation of the transplantation of encapsulated rat islets to the diabetic mice. 包封大鼠胰岛移植治疗糖尿病小鼠的长期观察。
C Shu, J He

Rat islets encapsulated in the immuno-isolated membrane were transplanted intraperitoneally into 11 streptozotocin induced diabetic mice. The effective rate was 91% while all rejected in the 11 nonencapsulated xenograft group. 4 mice showed complete remission and longest normoglycemic period in those mice was 360 days. The pathological changes of islets of the long-term successful xenograft group were studied and showed atrophy. It proved that the immuno-isolated membrane can protect rejection during xeno-transplantation.

将包被免疫分离膜的大鼠胰岛腹腔移植至11只链脲佐菌素诱导的糖尿病小鼠。非包膜异种移植物组11例全部排斥,有效率91%。4只小鼠血糖完全缓解,正常血糖持续时间最长为360天。观察长期移植成功组胰岛的病理变化,发现胰岛萎缩。结果表明,免疫分离膜具有保护异种移植排斥反应的作用。
{"title":"The long-term observation of the transplantation of encapsulated rat islets to the diabetic mice.","authors":"C Shu,&nbsp;J He","doi":"10.3109/10731199309118299","DOIUrl":"https://doi.org/10.3109/10731199309118299","url":null,"abstract":"<p><p>Rat islets encapsulated in the immuno-isolated membrane were transplanted intraperitoneally into 11 streptozotocin induced diabetic mice. The effective rate was 91% while all rejected in the 11 nonencapsulated xenograft group. 4 mice showed complete remission and longest normoglycemic period in those mice was 360 days. The pathological changes of islets of the long-term successful xenograft group were studied and showed atrophy. It proved that the immuno-isolated membrane can protect rejection during xeno-transplantation.</p>","PeriodicalId":77039,"journal":{"name":"Biomaterials, artificial cells, and immobilization biotechnology : official journal of the International Society for Artificial Cells and Immobilization Biotechnology","volume":"21 1","pages":"85-9"},"PeriodicalIF":0.0,"publicationDate":"1993-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3109/10731199309118299","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19444488","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Systemic hemodynamic and hepatic microvascular responses to a 33% blood volume exchange with whole blood, stroma-free hemoglobin, and oxypolyhemoglobin solutions. 33%血容量与全血、无基质血红蛋白和多氧血红蛋白溶液交换时的全身血流动力学和肝脏微血管反应。
I A Sherman, J A Dlugosz, V Perelman, C J Hsia, L T Wong, R M Condie

Little is known about the microvascular effects of blood replacement solutions. This study was undertaken to develop an animal model suitable for studies of the microcirculatory effects of such solutions and to investigate microvascular responses to isovolemic transfusion with stroma-free hemoglobin (SFH), whole donor blood, or a new potential blood substitute solution containing oxypolyhemoglobin (OPH) as an oxygen carrier. Hamster livers were exposed and the microcirculation studied using intravital epifluorescent video microscopy. 33% blood volume replacement with SFH elevated systemic blood pressure by 25 Torr. Accompanying this increase in pressure was a 36% decrease in sinusoidal blood flow velocity and a 10% decrease in terminal hepatic venular diameters. Terminal portal venular diameters did not change. Decrease in liver sinusoidal perfusion was not due to neutrophil mediated injury, as myeloperoxidase activity in jejunum, liver, kidney, and lung remained unchanged. The reduction in perfusion was likely due to systemic vasoconstriction produced by SFH. In contrast, transfusion with whole blood did not change any of the measured parameters showing the excellent stability of the model. OPH transfused animals exhibited only a small 10 Torr transient increase in MAP 15 min post-transfusion. By 30 min MAP returned to the pre-infusion value. No significant changes were observed in either venular diameters or sinusoidal velocities in this group of animals. These results demonstrate suitability of this model for studies of the microcirculatory and hemodynamic effects of blood replacement solutions. Furthermore, OPH solution produced only minor transient disturbances in microvascular and systemic parameters.

人们对血液替代溶液对微血管的影响知之甚少。本研究的目的是建立一种适合研究此类溶液的微循环作用的动物模型,并研究等容输血对无基质血红蛋白(SFH)、全供血或含有氧多血红蛋白(OPH)作为氧载体的新型潜在血液替代溶液的微血管反应。采用活体荧光视频显微镜观察鼠肝脏微循环。33%血容量替换SFH使全身血压升高25托。伴随着压力的增加,正弦血流速度下降36%,末端肝静脉直径下降10%。门静脉终末直径没有变化。肝窦灌注减少不是由于中性粒细胞介导的损伤,因为空肠、肝、肾和肺的髓过氧化物酶活性保持不变。灌注减少可能是由于SFH引起的全身血管收缩。相比之下,全血输血没有改变任何测量参数,显示了模型的良好稳定性。OPH输注的动物在输血后15分钟内MAP仅出现10 Torr的短暂性升高。30 min后MAP恢复到注射前值。在这组动物中,静脉直径和正弦速度都没有明显的变化。这些结果表明,该模型适合研究血液替代溶液的微循环和血流动力学效应。此外,OPH溶液仅对微血管和全身参数产生轻微的短暂干扰。
{"title":"Systemic hemodynamic and hepatic microvascular responses to a 33% blood volume exchange with whole blood, stroma-free hemoglobin, and oxypolyhemoglobin solutions.","authors":"I A Sherman,&nbsp;J A Dlugosz,&nbsp;V Perelman,&nbsp;C J Hsia,&nbsp;L T Wong,&nbsp;R M Condie","doi":"10.3109/10731199309117656","DOIUrl":"https://doi.org/10.3109/10731199309117656","url":null,"abstract":"<p><p>Little is known about the microvascular effects of blood replacement solutions. This study was undertaken to develop an animal model suitable for studies of the microcirculatory effects of such solutions and to investigate microvascular responses to isovolemic transfusion with stroma-free hemoglobin (SFH), whole donor blood, or a new potential blood substitute solution containing oxypolyhemoglobin (OPH) as an oxygen carrier. Hamster livers were exposed and the microcirculation studied using intravital epifluorescent video microscopy. 33% blood volume replacement with SFH elevated systemic blood pressure by 25 Torr. Accompanying this increase in pressure was a 36% decrease in sinusoidal blood flow velocity and a 10% decrease in terminal hepatic venular diameters. Terminal portal venular diameters did not change. Decrease in liver sinusoidal perfusion was not due to neutrophil mediated injury, as myeloperoxidase activity in jejunum, liver, kidney, and lung remained unchanged. The reduction in perfusion was likely due to systemic vasoconstriction produced by SFH. In contrast, transfusion with whole blood did not change any of the measured parameters showing the excellent stability of the model. OPH transfused animals exhibited only a small 10 Torr transient increase in MAP 15 min post-transfusion. By 30 min MAP returned to the pre-infusion value. No significant changes were observed in either venular diameters or sinusoidal velocities in this group of animals. These results demonstrate suitability of this model for studies of the microcirculatory and hemodynamic effects of blood replacement solutions. Furthermore, OPH solution produced only minor transient disturbances in microvascular and systemic parameters.</p>","PeriodicalId":77039,"journal":{"name":"Biomaterials, artificial cells, and immobilization biotechnology : official journal of the International Society for Artificial Cells and Immobilization Biotechnology","volume":"21 4","pages":"537-51"},"PeriodicalIF":0.0,"publicationDate":"1993-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3109/10731199309117656","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19248297","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 18
Nonspecific adsorption and covalent coupling of heparin on polyacrylate based microbeads. 肝素在聚丙烯酸酯微球上的非特异性吸附和共价偶联。
A Denizli, M Kiremitçi, E Pişkin

Polyacrylate based microbeads were prepared by copolymerization of four different acrylate monomers, namely 2-hydroxyethylmethacrylate (HEMA), ethyleneglycoldimethacrylate (EGDMA), methylmethacrylate (MMA) and dimethylaminoethylmethacrylate (DMEAMA). These beads were further activated with CNBr at alkaline pH. The extend of nonspecific adsorption and covalent coupling of heparin on these beads were investigated in a batch reactors at different temperatures. The effects of initial concentrations of activation agent and heparin were also studied. Nonspecific heparin adsorption on the microbeads containing DMAEMA was significantly higher than the others. Nonspecific adsorption decreased with increasing temperature. Heparin was covalently coupled on CNBr activated microbeads. The amount of coupled heparin increased by increasing concentration of CNBr.

以2-羟乙基甲基丙烯酸酯(HEMA)、乙二醇二甲基丙烯酸酯(EGDMA)、甲基丙烯酸甲酯(MMA)和二甲氨基甲基丙烯酸乙酯(DMEAMA)四种不同的丙烯酸酯单体为共聚物,制备了聚丙烯酸酯基微球。在碱性条件下,用CNBr进一步活化这些微球。在不同温度下,研究了这些微球对肝素的非特异性吸附和共价偶联的程度。研究了活化剂初始浓度和肝素初始浓度的影响。非特异性肝素在含DMAEMA微球上的吸附显著高于其他微球。非特异性吸附随温度升高而降低。肝素在CNBr活化微球上共价偶联。随着CNBr浓度的增加,偶联肝素的量增加。
{"title":"Nonspecific adsorption and covalent coupling of heparin on polyacrylate based microbeads.","authors":"A Denizli,&nbsp;M Kiremitçi,&nbsp;E Pişkin","doi":"10.3109/10731199309117356","DOIUrl":"https://doi.org/10.3109/10731199309117356","url":null,"abstract":"<p><p>Polyacrylate based microbeads were prepared by copolymerization of four different acrylate monomers, namely 2-hydroxyethylmethacrylate (HEMA), ethyleneglycoldimethacrylate (EGDMA), methylmethacrylate (MMA) and dimethylaminoethylmethacrylate (DMEAMA). These beads were further activated with CNBr at alkaline pH. The extend of nonspecific adsorption and covalent coupling of heparin on these beads were investigated in a batch reactors at different temperatures. The effects of initial concentrations of activation agent and heparin were also studied. Nonspecific heparin adsorption on the microbeads containing DMAEMA was significantly higher than the others. Nonspecific adsorption decreased with increasing temperature. Heparin was covalently coupled on CNBr activated microbeads. The amount of coupled heparin increased by increasing concentration of CNBr.</p>","PeriodicalId":77039,"journal":{"name":"Biomaterials, artificial cells, and immobilization biotechnology : official journal of the International Society for Artificial Cells and Immobilization Biotechnology","volume":"21 2","pages":"183-98"},"PeriodicalIF":0.0,"publicationDate":"1993-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3109/10731199309117356","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19305918","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
A liposome based platelet substitute, the plateletsome, with hemostatic efficacy. 一种基于脂质体的血小板替代物,血小板体,具有止血功效。
M E Rybak, L A Renzulli

The complexity of platelet mediated hemostasis has hindered development of a platelet substitute for transfusion therapy. In the current study, the hemostatic efficacy of a liposome based modality, the plateletsome, is demonstrated. A deoxycholate extract of a platelet membrane fraction, with a minimum of 15 proteins including GPIb, GPIIb-IIIa and GPIV/III, was incorporated into sphingomyelin: phosphatidylcholine: monosialylganglioside or egg phosphatide small unilamellar vesicles by reverse-phase/sonication and French press extrusion. These plateletsomes decreased bleeding by 67% in the tail bleeding time in rats made thrombocytopenic (platelets < 30,000/microliters) with external irradiation (7-9Gy) by Cesium source. Efficacy was also demonstrated in the thrombocytopathic, Fawn-Hooded rat, but to a lesser extent than in the thrombocytopenic animals. Direct plateletsome infusion to the tail wound was more effective than systemic administration for all effective preparations. On post-mortem examination, no pathologic thrombi were detected by gross and histopathologic examination of the lungs, livers, kidneys, or spleens of thrombocytopenic or normal animals after plateletsome infusion. No evidence of intravascular coagulation, monitored by levels of circulating fibrinogen and platelet counts, was observed when plateletsomes were administered intravenously to rabbits. No deleterious effect, either inhibition or hyperaggregability, on platelet aggregation studies in vitro was observed. While further refinements are clearly required, this study indicates that liposomes bearing specific platelet proteins may provide a basis for a clinically applicable platelet substitute.

血小板介导止血的复杂性阻碍了血小板替代输血治疗的发展。在目前的研究中,一种基于脂质体的止血效果,血小板,被证明。血小板膜部分脱氧胆酸提取物,至少含有15种蛋白质,包括GPIb, GPIIb-IIIa和GPIV/III,通过反相/超声和法压挤压纳入鞘磷脂、磷脂酰胆碱、单唾液神经节苷脂或蛋磷脂小单层囊泡。这些血小板体在铯源外照射(7-9Gy)致血小板减少(血小板< 30,000/微升)大鼠尾出血时间内可减少出血67%。效果也证明了在血小板病变,小鹿兜帽大鼠,但在较小程度上比在血小板减少的动物。在所有有效制剂中,尾创面直接输注血小板比全身给药更有效。死后检查,血小板减少或正常动物输注血小板后肺、肝、肾、脾的大体和组织病理学检查均未发现病理性血栓。通过循环纤维蛋白原水平和血小板计数监测,当血小板体静脉注射给兔时,没有观察到血管内凝血的证据。在体外的血小板聚集研究中,没有观察到抑制或超聚集的有害作用。虽然还需要进一步的改进,但这项研究表明,含有特异性血小板蛋白的脂质体可能为临床应用的血小板替代品提供基础。
{"title":"A liposome based platelet substitute, the plateletsome, with hemostatic efficacy.","authors":"M E Rybak,&nbsp;L A Renzulli","doi":"10.3109/10731199309117350","DOIUrl":"https://doi.org/10.3109/10731199309117350","url":null,"abstract":"<p><p>The complexity of platelet mediated hemostasis has hindered development of a platelet substitute for transfusion therapy. In the current study, the hemostatic efficacy of a liposome based modality, the plateletsome, is demonstrated. A deoxycholate extract of a platelet membrane fraction, with a minimum of 15 proteins including GPIb, GPIIb-IIIa and GPIV/III, was incorporated into sphingomyelin: phosphatidylcholine: monosialylganglioside or egg phosphatide small unilamellar vesicles by reverse-phase/sonication and French press extrusion. These plateletsomes decreased bleeding by 67% in the tail bleeding time in rats made thrombocytopenic (platelets < 30,000/microliters) with external irradiation (7-9Gy) by Cesium source. Efficacy was also demonstrated in the thrombocytopathic, Fawn-Hooded rat, but to a lesser extent than in the thrombocytopenic animals. Direct plateletsome infusion to the tail wound was more effective than systemic administration for all effective preparations. On post-mortem examination, no pathologic thrombi were detected by gross and histopathologic examination of the lungs, livers, kidneys, or spleens of thrombocytopenic or normal animals after plateletsome infusion. No evidence of intravascular coagulation, monitored by levels of circulating fibrinogen and platelet counts, was observed when plateletsomes were administered intravenously to rabbits. No deleterious effect, either inhibition or hyperaggregability, on platelet aggregation studies in vitro was observed. While further refinements are clearly required, this study indicates that liposomes bearing specific platelet proteins may provide a basis for a clinically applicable platelet substitute.</p>","PeriodicalId":77039,"journal":{"name":"Biomaterials, artificial cells, and immobilization biotechnology : official journal of the International Society for Artificial Cells and Immobilization Biotechnology","volume":"21 2","pages":"101-18"},"PeriodicalIF":0.0,"publicationDate":"1993-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3109/10731199309117350","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19306557","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 67
A new bioencapsulation technology for microbial inoculants. 用于微生物接种剂的新型生物胶囊技术。
B Digat
{"title":"A new bioencapsulation technology for microbial inoculants.","authors":"B Digat","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":77039,"journal":{"name":"Biomaterials, artificial cells, and immobilization biotechnology : official journal of the International Society for Artificial Cells and Immobilization Biotechnology","volume":"21 3","pages":"299-306"},"PeriodicalIF":0.0,"publicationDate":"1993-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19385901","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Skin sensitization study of a new BIS-GMA based dental restorative material. 一种新型BIS-GMA牙体修复材料的皮肤致敏研究。
K Rathinam, P V Mohanan

One of the criteria for the Dental Restorative Material is to not to evoke sensitization reaction when used clinically. The newly synthesized BIS-GMA based Chitra's Dental Material intended for such application was tested for skin sensitization as per the international protocol of test i.e. skin Maximization test in G.Pig. Result of this test showed conclusively that the material is devoid of sensitization potential and fit for clinical application.

牙科修复材料的标准之一是临床使用时不引起致敏反应。新合成的基于BIS-GMA的Chitra牙科材料用于此类应用,根据国际测试协议(即g.g pig皮肤最大化测试)进行皮肤致敏测试。试验结果表明,该材料无致敏性,适合临床应用。
{"title":"Skin sensitization study of a new BIS-GMA based dental restorative material.","authors":"K Rathinam,&nbsp;P V Mohanan","doi":"10.3109/10731199309118300","DOIUrl":"https://doi.org/10.3109/10731199309118300","url":null,"abstract":"<p><p>One of the criteria for the Dental Restorative Material is to not to evoke sensitization reaction when used clinically. The newly synthesized BIS-GMA based Chitra's Dental Material intended for such application was tested for skin sensitization as per the international protocol of test i.e. skin Maximization test in G.Pig. Result of this test showed conclusively that the material is devoid of sensitization potential and fit for clinical application.</p>","PeriodicalId":77039,"journal":{"name":"Biomaterials, artificial cells, and immobilization biotechnology : official journal of the International Society for Artificial Cells and Immobilization Biotechnology","volume":"21 1","pages":"91-6"},"PeriodicalIF":0.0,"publicationDate":"1993-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3109/10731199309118300","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19444489","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Biomaterials, artificial cells, and immobilization biotechnology : official journal of the International Society for Artificial Cells and Immobilization Biotechnology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1